Company news-新闻动态-Abrev Biotechnology Co., Ltd.

EN 中文

Home > News

There is also an expert consensus on the diagnosis and treatment of lymphoma associated hemophagocytic syndrome. Hemophagocytic syndrome (HPS) is also known as Haemophilus lymphohistiocytosis (HLH). Lymphoma is one of the important causes of HLH. Lymphoma related HLH is a primary cause of HLH or HLH in lymphoma treatment. According to the time difference, it is clas 2018-07-13

Super three notifications, these drugs are not used There was no consensus on the purchase of new drugs in tertiary hospitals. New drug declaration, 4 doorsill In June 25th, a large 3A hospital in southwest issued the announcement on the receipt of new drug information on the official website. The declar 2018-07-13

FDA officials: next year, there will be a large number of medical AI listing reviews. "It is expected that next year there will be a large number of independent medical Al software entering the stage of listing review." Sun Lei, director of the Medical Devices Technical Review Center, said July 2 that the center has not yet received an app 2018-07-13

Annie bio provides antibody support for your life science research. We assist you in implementing your mission as soon as possible. Annie bio provides antibody support for your life science research. We assist you in implementing your mission as soon as possible. 2018-07-10

Related news

Annie bio provide 2018-07-10

A new round of me 2018-07-13

FDA officials: ne 2018-07-13

Super three notif 2018-07-13

Home